Oxalo Therapeutics' Biz Plan Competition Round

Oxalo Therapeutics raised a round of funding on May 31, 2018. Investors include University of Chicago's New Venture Challenge.

Oxalo Therapeutics is developing a drug therapy to treat and prevent recurrent kidney stones, as well as other renal diseases caused by high levels of oxalate in the body.…

Articles about Oxalo Therapeutics' Biz Plan Competition Round: